Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link from the footer, updating the page metadata; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedRecord History now shows Revision: v3.3.2 added and v3.3.1 removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision history updated to include v3.3.1 and remove v3.2.0.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page removed the government funding disclaimer about potential delays and the NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check81 days agoChange DetectedThe study record history shows only the initial version (2023-04-17) with no changes listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check110 days agoChange DetectedAdded a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference13%

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.